共 113 条
[11]
Guo Q(2013)Limitations of a single-point evaluation of anti-MDA5 antibody, ferritin, and IL-18 in predicting the prognosis of interstitial lung disease with anti-MDA5 antibody-positive dermatomyositis Clin Rheumatol 32 395-402
[12]
Chi J(2019)Improved quantification of a commercial enzyme-linked immunosorbent assay kit for measuring anti-MDA5 antibody Mod Rheumatol 29 140-1726
[13]
Wu H(2016)Anti–melanoma differentiation–associated gene 5 is associated with rapidly progressive lung disease and poor survival in US patients with Amyopathic and Myopathic dermatomyositis Arthritis Care Res 68 689-76
[14]
Bao C(2017)Antimelanoma differentiation-associated protein 5 antibody level is a novel tool for monitoring disease activity in rapidly progressive interstitial lung disease with dermatomyositis Br J Dermatol 176 395-1570
[15]
Ariani A(2005)Combination therapy with corticosteroids, cyclosporin A, and intravenous pulse cyclophosphamide for acute/subacute interstitial pneumonia in patients with dermatomyositis J Rheumatol 32 1719-752
[16]
Aiello M(2013)Anti-MDA5 (melanoma differentiation-associated gene 5) antibody and dermatomyositis with rapidly progressive interstitial pneumonia Nihon Rinsho Meneki Gakkai Kaishi 36 71-206
[17]
Silva M(2012)Anti-MDA5 antibody, ferritin and IL-18 are useful for the evaluation of response to treatment in interstitial lung disease with anti-MDA5 antibody-positive dermatomyositis Rheumatology 51 1563-1428
[18]
Chen A(2013)The prognostic value of HRCT in myositis-associated interstitial lung disease Respir Med 107 745-3292
[19]
Karwoski RA(2009)Intravenous immunoglobulin therapy for refractory interstitial lung disease associated with polymyositis/dermatomyositis Lung 187 201-5
[20]
Gierada DS(2015)Long-term experience with rituximab in anti-synthetase syndrome-related interstitial lung disease Rheumatology 54 1420-540